Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 0964020100100010052
Journal of the Korean Liver Cancer Study Group
2010 Volume.10 No. 1 p.52 ~ p.54
A Case of Pulmonary Metastasis from Hepatocellular Carcinoma Partially Responsive to Sorafenib
Heo Nae-Yun

Lee Yung-Sang
Suh Dong-Jin
Chung Young-Hwa
Lim Young-Suk
Shim Ju-Hyun
Lee Han-Chu
Abstract
Hepatocellular carcinoma (HCC) is one of the most important causes of cancer death in South Korea. Unfortunately, more
than half of the patients are diagnosed in the advanced stage with multiple intra- or extrahepatic metastasis, so no more than 30% of patients are suitable to undergo curative resection. Lung is the most common organ of extrahepatic metastasis of HCC, and the pulmonary metastasis is known as poor prognosis factor, but no standard systemic therapy is established yet. Sorafenib is the only molecularly targeted agent which has been proven clinical benefit in the randomized clinical trials, but pulmonary metastasis is known as predictive factor of poor response. However, we experience a case of pulmonary metastasis from hepatocellular carcinoma partially responsive to sorafenib, and report it.
KEYWORD
Pulmonary metastasis, Hepatocellular carcinoma, Sorafenib
FullTexts / Linksout information
Listed journal information